The report gives detail analysis of the market structure along with forecast, market size & share, different segments and developing trends of the industry.
Blood Coagulation Testing market-Overview
Blood coagulation is a process of blood clot formation. In case of patients suffering from chronic and fatal diseases such as haemophilia, liver disease, thrombophilia the process of blood clotting is found is hindered.
Blood coagulants, are natural and synthetic substances that are used to stop blood resulting from an injury or surgery.
Get Sample Copy for Future Advancements @ https://www.marketresearchfuture.com/sample_request/970
The market for blood coagulation testing is found to exhibit positive growth owing to the rising prevalence of cancer, and increasing demand screening test for chronic diseases.
However, high cost of diagnostic devices is a major factor hindering the growth of the market.
Blood Coagulation Testing market-Key players
- Hoffmann-La Roche Ltd. (Europe)
- Alere Inc. (U.S.)
- Siemens Healthcare Private Limited (Europe)
- Accriva Diagnostics (U.S.A.)
- CoaguSense, Inc. (U.S.)
- HomoSonics LLC. (U.S.)
- iLine Microsystems. (Europe)
- Instrumentation Laboratory (U.S.)
- Sienco, Inc. (U.S.)
- SenGenix Inc. (U.S.)
- Bio/Data Corporation (U.S.)
Blood Coagulation Testing market-Key developments
Strategic approaches adopted help the major players to sustain their growth in the market and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players.
Pfizer
July 2016: Pfizer and Western Oncolytics announce immuno-oncology research collaboration. This collaboration was initiated with the aim of investigating novel oncolytic virus technology.
June 2016: Pfizer completed the acquisition of Anacor Pharmaceuticals.
Read Comprehensive Overview of Report @ https://www.marketresearchfuture.com/reports/blood-coagulation-testing-market-970
Hoffmann-La Roche Ltd.
April 2017: F. Hoffmann-La Roche Ltd. received 510(k) clearance from the U.S. FDA for the CINtec Histology test.
March 2017: F. Hoffmann-La Roche Ltd. launched CE-IVD launch of cobas HPV for use on the cobas 6800/8800 Systems for cervical cancer screening.
August 2015: F. Hoffmann-La Roche Ltd. acquired GeneWEAVE to strengthen offerings in microbiology diagnostics.
Alere
August 2016: Alere opens new diagnostics manufacturing facility in India. By this expansion the Manesar facility will have capacity to double production to more than 300 million tests over time.
July 2015: Alere to sell BBI Group and acquisition of US diagnostics.
Global Blood Coagulation Testing Market
North America dominates the Americas blood coagulation testing market. North America is further segmented into the U.S. and Canada.
The U.S. holds the major share of the market owing to a well-developed economy and the government support for research & development. South America is still a developing region in terms of the infrastructure and technology.
As per the report published by the Centre for Disease Control and Prevention (CDC), in October 2017, around 22,000 males and 9000 females in the United States were diagnosed with liver cancer.
According to American Cancer Society, (2017) About 222,500 new cases of lung cancer (116,990 in men and 105,510 in women) and about 155,870 deaths from lung cancer (84,590 in men and 71,280 in women) in U.S. As per American Cancer Society’s (2017) estimated About 63,990 new cases of kidney cancer (40,610 in men and 23,380 in women) will occur and about 14,400 people (9,470 men and 4,930 women) will die from this disease. According to the WHO estimates, brain associated disorders are responsible for 4.5%-11% of all illnesses including low or high income economies.
For Exclusive Discount Visit @ https://www.marketresearchfuture.com/check-discount/970
Major Points form TOC for Blood Coagulation Testing Market Research Report – Forecast to 2023
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Blood Coagulation Testing Market, By Type
Chapter 7. Global Blood Coagulation Testing Market, By Treatment
Chapter 8 Global Blood Coagulation Testing Market, By End User
Chapter 9. Global Blood Coagulation Testing Market, By Region
Chapter 10. Company Landscape
Chapter 11. Company Profiles
Chapter 12. MRFR Conclusion
Chapter 13. Appendix
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Your information will never be shared with any third party.